$VIR
Vir Biotechnology, Inc.

2020 Q2 Form 10-Q Financial Statement

#000156459020039295 Filed on August 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q2
Revenue $66.99M $5.718M $2.047M
YoY Change 3172.5% 56.19% -7.96%
Cost Of Revenue $0.00
YoY Change
Gross Profit $66.99M
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $16.39M $12.65M $8.010M
YoY Change 104.57% 47.78%
% of Gross Profit 24.46%
Research & Development $79.65M $64.98M $29.21M
YoY Change 172.69% 151.16%
% of Gross Profit 118.91%
Depreciation & Amortization $1.100M $1.000M $800.0K
YoY Change 37.5% 42.86% -28.57%
% of Gross Profit 1.64%
Operating Expenses $96.04M $77.63M $37.82M
YoY Change 153.96% 125.46% 38.94%
Operating Profit -$29.05M -$71.91M
YoY Change 133.7%
Interest Expense $830.0K $1.760M $2.310M
YoY Change -64.07% -21.78%
% of Operating Profit
Other Income/Expense, Net -$2.070M -$5.314M -$450.0K
YoY Change 360.0% -353.05%
Pretax Income -$31.12M -$77.22M -$33.91M
YoY Change -8.22% 169.35%
Income Tax $46.00K $16.00K $20.00K
% Of Pretax Income
Net Earnings -$31.17M -$77.24M -$33.93M
YoY Change -8.14% 169.41% 38.79%
Net Earnings / Revenue -46.53% -1350.82% -1657.45%
Basic Earnings Per Share -$0.27 -$0.71 -$3.64
Diluted Earnings Per Share -$0.27 -$0.71 -$3.64
COMMON SHARES
Basic Shares Outstanding 115.0M 109.8M
Diluted Shares Outstanding 115.0M

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $552.4M $355.6M $356.5M
YoY Change 54.95%
Cash & Equivalents $371.8M $168.4M $80.68M
Short-Term Investments $180.6M $187.2M $275.9M
Other Short-Term Assets $26.40M $21.90M $20.80M
YoY Change 26.92%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $578.8M $377.5M $377.4M
YoY Change 53.35%
LONG-TERM ASSETS
Property, Plant & Equipment $16.31M $16.24M $15.40M
YoY Change 5.92%
Goodwill $16.94M
YoY Change
Intangibles $35.08M
YoY Change
Long-Term Investments $0.00 $6.100M
YoY Change
Other Assets $10.00M $8.900M $10.80M
YoY Change -7.41%
Total Long-Term Assets $93.48M $99.60M $79.40M
YoY Change 17.73%
TOTAL ASSETS
Total Short-Term Assets $578.8M $377.5M $377.4M
Total Long-Term Assets $93.48M $99.60M $79.40M
Total Assets $672.2M $477.1M $456.8M
YoY Change 47.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.382M $18.80M $4.100M
YoY Change 6.88%
Accrued Expenses $38.30M $21.70M $18.40M
YoY Change 108.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $200.0K
YoY Change
Total Short-Term Liabilities $54.94M $56.40M $40.70M
YoY Change 34.99%
LONG-TERM LIABILITIES
Long-Term Debt $800.0K $800.0K $0.00
YoY Change
Other Long-Term Liabilities $2.967M $36.30M $13.20M
YoY Change -77.52%
Total Long-Term Liabilities $2.967M $37.10M $13.20M
YoY Change -77.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $54.94M $56.40M $40.70M
Total Long-Term Liabilities $2.967M $37.10M $13.20M
Total Liabilities $108.5M $96.80M $57.20M
YoY Change 89.61%
SHAREHOLDERS EQUITY
Retained Earnings -$476.9M -$445.8M
YoY Change
Common Stock $12.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $563.8M $380.3M -$237.0M
YoY Change
Total Liabilities & Shareholders Equity $672.2M $477.1M $456.8M
YoY Change 47.16%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q2
OPERATING ACTIVITIES
Net Income -$31.17M -$77.24M -$33.93M
YoY Change -8.14% 169.41% 38.79%
Depreciation, Depletion And Amortization $1.100M $1.000M $800.0K
YoY Change 37.5% 42.86% -28.57%
Cash From Operating Activities -$10.64M -$48.41M -$24.30M
YoY Change -56.21% 64.16% -18.95%
INVESTING ACTIVITIES
Capital Expenditures -$1.350M $1.302M -$2.650M
YoY Change -49.06% -62.54% -52.76%
Acquisitions
YoY Change
Other Investing Activities $11.93M $105.5M $47.14M
YoY Change -74.69% -138.98% -152.79%
Cash From Investing Activities $10.58M $104.2M $44.48M
YoY Change -76.21% -138.01% -146.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 205.3M 85.00K 0.000
YoY Change -99.97% -100.0%
NET CHANGE
Cash From Operating Activities -10.64M -48.41M -24.30M
Cash From Investing Activities 10.58M 104.2M 44.48M
Cash From Financing Activities 205.3M 85.00K 0.000
Net Change In Cash 205.3M 55.90M 20.18M
YoY Change 917.24% 306.33% -117.93%
FREE CASH FLOW
Cash From Operating Activities -$10.64M -$48.41M -$24.30M
Capital Expenditures -$1.350M $1.302M -$2.650M
Free Cash Flow -$9.290M -$49.71M -$21.65M
YoY Change -57.09% 50.8% -11.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.222222222
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2019Q3 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P5Y
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2020Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:AccruedLiabilitiesAndOtherLiabilities
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.957
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.888
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.006
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.006
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.004
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.004
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.005
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.012
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
24290000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
563779000
us-gaap Revenues
Revenues
5708000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55677000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29035000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16570000
us-gaap Operating Expenses
OperatingExpenses
72247000
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16308000
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
371781000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
11024000
CY2020Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
180599000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13378000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
35694000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
402995000
CY2019Q4 us-gaap Goodwill
Goodwill
16937000
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
26495000
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
8200000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
54940000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3305000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107648925
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-601000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-368519000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12762000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
793051000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
11000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
423942000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
477114000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16311000
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4700000
dei Entity File Number
EntityFileNumber
001-39083
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2730369
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
35082000
dei Entity Address Address Line1
EntityAddressAddressLine1
499 Illinois Street, Suite 500,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020Q2 us-gaap Goodwill
Goodwill
16937000
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94158
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109335000
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
906-4324
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3815000
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
30670000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1192000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
6181000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15357000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
578761000
dei Document Transition Report
DocumentTransitionReport
false
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15177000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q2 us-gaap Other Assets
OtherAssets
8778000
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
274101000
CY2020Q2 us-gaap Assets
Assets
672238000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
117727086
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4382000
CY2020Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
38560000
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7298000
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
12449000
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
117727086
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3305000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2967000
CY2020Q2 us-gaap Liabilities
Liabilities
108459000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1040988000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107648925
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
12000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-295000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-476926000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
144632000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
672238000
us-gaap Operating Expenses
OperatingExpenses
173667000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2580000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.97
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62000
us-gaap Net Income Loss
NetIncomeLoss
-108407000
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.64
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9327651
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
111684283
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-33928000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2388000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
254000
us-gaap Operating Income Loss
OperatingIncomeLoss
-100961000
us-gaap Operating Income Loss
OperatingIncomeLoss
-66539000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62579000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000
us-gaap Net Income Loss
NetIncomeLoss
-62598000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.83
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9165311
us-gaap Net Income Loss
NetIncomeLoss
-62598000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
145000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
295000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
254000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-11000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
254000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-62344000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
380333000
CY2020Q2 vir Stock Issued During Period Value Collaboration Agreement
StockIssuedDuringPeriodValueCollaborationAgreement
206699000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
462000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2245000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5750000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-543000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-31167000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
563779000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-205218000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
635000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1399000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
145000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-33928000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-236967000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
423942000
vir Reclassification Of Derivative Liability To Additional Paid In Capital
ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapital
29245000
vir Stock Issued During Period Value Collaboration Agreement
StockIssuedDuringPeriodValueCollaborationAgreement
206699000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
889000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8717000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
306000
us-gaap Net Income Loss
NetIncomeLoss
-108407000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
563779000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-179177000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
702000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3852000
us-gaap Net Income Loss
NetIncomeLoss
-62598000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-236967000
us-gaap Profit Loss
ProfitLoss
-108407000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1220000
vir Noncash Lease Expense
NoncashLeaseExpense
1646000
vir Change In Estimated Fair Value Of Contingent Consideration
ChangeInEstimatedFairValueOfContingentConsideration
27790000
vir Change In Estimated Fair Value Of Contingent Consideration
ChangeInEstimatedFairValueOfContingentConsideration
350000
vir Increase Decrease In Payment Of Contingent Consideration In Excess Of Acquisition Date Fair Value
IncreaseDecreaseInPaymentOfContingentConsiderationInExcessOfAcquisitionDateFairValue
-6453000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-16796000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
784000
us-gaap Share Based Compensation
ShareBasedCompensation
8717000
us-gaap Share Based Compensation
ShareBasedCompensation
3852000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
11000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2159000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
653000
us-gaap Profit Loss
ProfitLoss
-62598000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2061000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1533000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
612000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
612000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-818000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
361000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
212000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1342000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-833000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6791000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1691000
vir Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1557000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4011000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2902000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-59048000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53792000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2645000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6131000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
129899000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
360021000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
247168000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
136471000
us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
180000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
114804000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-229681000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
206699000
vir Payment Of Contingent Consideration
PaymentOfContingentConsideration
3547000
vir Payments Related To Sale Lease Back Obligation
PaymentsRelatedToSaleLeaseBackObligation
115000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
625000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2388000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
702000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
205425000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
317412000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
261181000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33939000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122816000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59362000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
383997000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93301000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
312000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
526000
vir Reclassification Of Derivative Liability To Additional Paid In Capital Upon Achievement Of Development Milestone
ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapitalUponAchievementOfDevelopmentMilestone
29245000
vir Deferred Offering Costs In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsInAccountsPayableAndAccruedLiabilities
690000
vir Deferred Offering Costs In Accounts Payable And Accrued Liabilities
DeferredOfferingCostsInAccountsPayableAndAccruedLiabilities
2284000
vir Advanced Proceeds Applied To Convertible Preferred Stock Issuance
AdvancedProceedsAppliedToConvertiblePreferredStockIssuance
10140000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80678000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
11620000
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On September 16, 2019, the Company’s board of directors approved an amendment to the Company’s amended and restated certificate of incorporation to effect a 1-for-4.5 reverse split (“Reverse Split”) of shares of the Company’s common and convertible preferred stock, which was effected on September 27, 2019.
CY2019Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
126400000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-476900000
CY2020Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
552400000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expense during the reporting periods. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates. </p>
vir Lease Arrangement Contractual Expiration Beginning Year
LeaseArrangementContractualExpirationBeginningYear
2020
CY2020Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
38560000
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
26495000
us-gaap Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Embedded Derivatives</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company evaluates certain of its acquisitions, collaborative arrangements and other business development transactions to determine if embedded components of these contracts meet the definition of a derivative under Topic ASC 815, Derivatives and Hedging. In general, embedded derivatives are required to be bifurcated from the host instrument if (i) the embedded feature is not clearly and closely related to the host contract and (ii) the embedded feature, if considered a freestanding instrument, meets the definition of a derivative. The embedded derivatives are reported on the condensed consolidated balance sheets at their estimated fair values. Specifically, any contingent consideration related to an asset acquisition that meets the definition of an embedded derivative  are classified as contingent consideration on the condensed consolidated balance sheets. Any change in estimated fair values, as determined at each measurement period, are recorded in the condensed consolidated statements of operations based on the nature of the related contingencies.<span style="font-size:8pt;"> </span>The changes in fair values of an embedded derivative related to achievement of various milestones related to product candidates are recorded within research and development expense. Otherwise, the changes in fair values are recorded within other income (expense), net.</p>
CY2020Q2 vir Financial Assets Amortized Cost Basis
FinancialAssetsAmortizedCostBasis
562111000
CY2020Q2 vir Financial Assets Gross Unrealized Holding Gains
FinancialAssetsGrossUnrealizedHoldingGains
433000
CY2020Q2 vir Financial Assets Gross Unrealized Holding Losses
FinancialAssetsGrossUnrealizedHoldingLosses
3000
CY2020Q2 vir Financial Assets Fair Value
FinancialAssetsFairValue
562541000
CY2019Q4 vir Financial Assets Amortized Cost Basis
FinancialAssetsAmortizedCostBasis
406883000
CY2019Q4 vir Financial Assets Gross Unrealized Holding Gains
FinancialAssetsGrossUnrealizedHoldingGains
140000
CY2019Q4 vir Financial Assets Gross Unrealized Holding Losses
FinancialAssetsGrossUnrealizedHoldingLosses
5000
CY2019Q4 vir Financial Assets Fair Value
FinancialAssetsFairValue
407018000
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
400000
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
12400000
CY2020Q1 vir Fair Value Reclassification Of Derivative Liability To Additional Paid In Capital Upon Achievement Of Development Milestone
FairValueReclassificationOfDerivativeLiabilityToAdditionalPaidInCapitalUponAchievementOfDevelopmentMilestone
29200000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4832000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16311000
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
800000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23204000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21140000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6893000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16308000
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1100000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2100000
CY2019Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
800000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1500000
CY2019Q3 vir Sale Leaseback Transaction Proceeds From Financing Obligations
SaleLeasebackTransactionProceedsFromFinancingObligations
1200000
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
200000
CY2020Q2 vir Research And Development Expenses Current
ResearchAndDevelopmentExpensesCurrent
20945000
CY2019Q4 vir Research And Development Expenses Current
ResearchAndDevelopmentExpensesCurrent
12530000
CY2020Q2 vir Payroll And Related Expenses Current
PayrollAndRelatedExpensesCurrent
6336000
CY2019Q4 vir Payroll And Related Expenses Current
PayrollAndRelatedExpensesCurrent
9410000
CY2020Q2 vir Excess Funds Payable Under Grant Agreements Current
ExcessFundsPayableUnderGrantAgreementsCurrent
3820000
CY2019Q4 vir Excess Funds Payable Under Grant Agreements Current
ExcessFundsPayableUnderGrantAgreementsCurrent
94000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3138000
CY2020Q2 vir Restricted Stock Liability Current
RestrictedStockLiabilityCurrent
546000
CY2019Q4 vir Restricted Stock Liability Current
RestrictedStockLiabilityCurrent
1434000
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
244000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
237000
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2936000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1634000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
595000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1156000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1141000
us-gaap Operating Lease Cost
OperatingLeaseCost
2281000
us-gaap Operating Lease Payments
OperatingLeasePayments
2200000
vir Lease Arrangement Contractual Expiration Ending Year
LeaseArrangementContractualExpirationEndingYear
2028
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain lease agreements also provide the Company with the option to renew for additional periods ranging from one to five years.
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
162000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
317000
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
646000
us-gaap Variable Lease Cost
VariableLeaseCost
1240000
CY2020Q2 us-gaap Lease Cost
LeaseCost
1949000
us-gaap Lease Cost
LeaseCost
3838000
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.077
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2162000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4142000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4210000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4262000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2998000
CY2020Q2 vir Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1058000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18832000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2932000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
15900000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15177000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3138000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12762000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
15900000
CY2019Q2 vir Operating And Finance Rent Expense
OperatingAndFinanceRentExpense
1000000.0
vir Operating And Finance Rent Expense
OperatingAndFinanceRentExpense
2000000.0
CY2016Q3 us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2026-09-11
CY2020Q2 vir Common Stock Shares Issued For Conversion Of Warrants
CommonStockSharesIssuedForConversionOfWarrants
211774
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.894
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.894
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.025
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.025
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5750000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1399000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8717000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3852000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9777731
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
98320920

Files In Submission

Name View Source Status
0001564590-20-039295-index-headers.html Edgar Link pending
0001564590-20-039295-index.html Edgar Link pending
0001564590-20-039295.txt Edgar Link pending
0001564590-20-039295-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vir-10q_20200630.htm Edgar Link pending
vir-10q_20200630_htm.xml Edgar Link completed
vir-20200630.xsd Edgar Link pending
vir-20200630_cal.xml Edgar Link unprocessable
vir-20200630_def.xml Edgar Link unprocessable
vir-20200630_lab.xml Edgar Link unprocessable
vir-20200630_pre.xml Edgar Link unprocessable
vir-ex1012_223.htm Edgar Link pending
vir-ex311_8.htm Edgar Link pending
vir-ex312_6.htm Edgar Link pending
vir-ex321_7.htm Edgar Link pending